Betamethasone Valerate

   
Google
 
Web NewDrugInformation.com

Betamethasone Valerate


Drug - Betamethasone Valerate
The trade name of the product as shown on the labeling.

Dosage - OINTMENT; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Betamethasone Valerate
Multiple ingredients are in alphabetical order.

Strength - EQ 0.1% BASE
The potency of the active ingredient(s), Betamethasone Valerate. May repeat for multiple part products.

Applicant - PHARMAFAIR
The firm name holding legal responsibility for Betamethasone Valerate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 070486
The FDA assigned number to Betamethasone Valerate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Betamethasone Valerate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 29, 1987
The date Betamethasone Valerate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Betamethasone Valerate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Betamethasone Valerate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmafair Inc
The full name of the firm holding legal responsibility for the new application of Betamethasone Valerate.

Betamethasone Valerate